D349-1738 Screening compound: N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-[2-(3-methyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide

D349-1738 Screening compound: N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-[2-(3-methyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide
D349-1738 Screening compound: N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-[2-(3-methyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D349-1738
N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-[2-(3-methyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D349-1738

Molecular Formula

C22H21N5O4 (C22 H21 N5 O4)

Compound Name

N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-[2-(3-methyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide

IUPAC name

N-(15-dimethyl-3-oxo-2-phenyl-23-dihydro-1H-pyrazol-4-yl)-2-[2-(3-methyl-124-oxadiazol-5-yl)phenoxy]acetamide

SMILES

CC(N(C)N(C1=O)c2ccccc2)=C1NC(COc(cccc1)c1-c1nc(C)no1)=O

InChI

InChI=1S/C22H21N5O4/c1-14-20(22(29)27(26(14)3)16-9-5-4-6-10-16)24-19(28)13-30-18-12-8-7-11-17(18)21-23-15(2)25-31-21/h4-12H,13H2,1-3H3,(H,24,28)

InChI Key

UWYATJHBDZISIO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27580667

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

419.44

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.418

Distribution Coefficient, logD

1.379

Water Solubility, LogSw

-2.09

Polar Surface Area

82.373

Acid Dissociation Constant (pKa)

8.43

Base Dissociation Constant (pKb)

-5.93

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

D349-1738 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with D349-1738 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D349-1738?
Check Price and Availability of D349-1738, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D349-1738 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D349-1738
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D349-1738
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D349-1738 available by request